• Psychedelic Drugs Welcome Guest
    View threads about
    Posting RulesBluelight Rules
    PD's Best Threads Index
    Social ThreadSupport Bluelight
    Psychedelic Beginner's FAQ
  • PD Moderators: Esperighanto | JackARoe |

Tryptamines Tabernanthalog(TBG) trip report 150mg

vesna

Greenlighter
Joined
Jul 15, 2026
Messages
3
11.2025 12:00 152mg Tabernanthalog

Contrary to the expectation, the taste was not repulsive, it tasted somewhat woody, the texture was sandy. I held it in my mouth for about 40 seconds under the tongue and on it, then swallowed with some rooibos tea.

12:38

Inner dialogue or should i better say monologue suddenly within 3-5 minutes became very loud, hard to hide from it or stop it, it doesn’t feel aggressive or threatening, but it is a distinctively unique experience. Also some kind of light euphoria, tingling in the heart and some lightness to the body.

12:51

Body feels a little chilly. The nature of thought is changed and it suggests me to behave cautiously.

13:38

A sense of improved well being, by now it produces distinctly psychedelic effect, although no perceptual distortions. Mind feels sensitive. I left my home for a walk in a forest and took a short bike ride to reach it, bike ride was confident, I felt no difficulty operating it and orienting in space.

13:58

Hearing is acute, as well as eye sight. Increased impressionability with visual stimuli.

14:30

Increased impressionability by music, walking from the forest to the city I behave cautiously despite feeling confident.

14:45

Distinct psychedelic body load, especially in the stomach, throat, mouth and heart.

15:30

I am home from the walk. Going to reheat a few spoons of rice with chicken.

15:55

Eating was pleasant, no nausea. Also ate a candy bar.

16:30

After some rest and a few pleasant communications with my roommate i begin reading a book. The drug effect is still there and feels as strong as the peak. Noticeable tingling throughout the body and waves of congetive pleasure. A definite strong ++.

17:15

Reading a book was not as smooth as I wanted it to be, so I am drinking a cup of caffeinated tea.

18:36

Book reading was enjoyable and amusing. The drug effect is diminishing but still faultlessly present

20:00

baseline
 
Wow! Thanks for sharing. I'm especially curious if it can be used like ibogaine for addiction therapy.

I also read another TR published here (you may need a paywall blocker)
 
  • Like
Reactions: iom
They keep calling this non-hallucinogenic, based on rodent behavior I guess, but the reports sure make it sound like a psychedelic to me. Also, non-hallucinogenic psychedelic is an oxymoron, isn't it? Here's another good one from that article (my emphasis):
The company Mindstate Design Labs even hopes to isolate and enhance the parts of a psychedelic trip that are therapeutically useful. If they’re successful, you could perhaps one day take a pill just for the psychedelic-induced sensation of limitless unity, without the ego loss that sometimes accompanies it.

There is also this: https://psychedelicalpha.com/news/n...rts-searching-for-the-tabernanthalog-tasters/

It's really a bit ridiculous to see all this "science-washing" of psychedelics in the process of bringing them into the mainstream when the root cause of their taint is the social taboo against tripping. That is still being ignored. Logically companies have the (profit) incentive to maintain these bizarre distinctions, because as long as "hallucinogens" remain illegal, these patentable "non-halluciongenic psychedelics" won't face legal market competition.

That's not to say I disapprove of this research. Ibogaine is physically risky, and a safer alternative (hopefully without losing the trip ;)) would be a huge win. Moreover, unlocking a mechanism for reseting opioid and other drug tolerances would also be a big deal.
 
great report! i gotta admit i am skeptical of these “non-hallucinogenic” psychedelics that have been cropping up. i’m in full support of psychedelics and their analogs being studied for psychiatric/neurological treatment. lately research and development has seemed focused on retaining the psychological and neurological benefits of psychedelics without the trip. and while not necessarily against it, i suppose i struggle to see how those could be separated. not that i don’t think they can be, but i just struggle to see it.

that being said, this report was definitely an interesting read on that topic. the impressionability you mentioned, was it alike to that of classical psychedelics? because i always found that trait of psyches to play a big role in all the trips and thoughts during that had significant positive impact on my mental health. being able to intentionally guide my train of thought to specific places and come to the conclusions that were best for me.

i feel like at least for me personally, lacking the hallucinogenic effect would make it harder for me to have that same psychiatric benefit. even outside of trips i have an incredibly visual brain, i can picture things in great detail and see them in my head. that’s amplified about 10x on psychedelics. in past positive trips it’s been a great benefit.

a few years back i developed a neurological movement disorder, Functional Neurological Disorder (or FND.) it caused muscle spasms, weakness, balance, gait issues, and involuntary movements (among other symptoms.) FND isn’t super understood but currently it’s largely understood as a software problem, not a hardware problem (tho some studies suggest it likely has a physical factor.) your brain sends the wrong signals to the wrong places. recovery largely consists of retraining your brain through physical therapy, CBT and psychotherapy, stress management, etc. it took me months to get into treatment. and in that time when i would trip, i could almost see the disconnect in my nervous system. while tripping i would focus on it and focus on my difficulty walking, focusing and forcing myself to walk normally and control the spasms, helping my brain remember how it feels to walk correctly. retraining my brain into remembering how to control my movement. and it felt as though i could see my brain overwriting the current issue and disconnect, saving the correct movements one neuron at a time. after a while i got into proper treatment and have made significant improvements. but i largely credit LSD and psilocybin to the large strides and initial beginning stage of recovery i made on my own before getting into professional treatment.

anyhoo, this post turned into a novel. all that is to say, as interested as i am to see how well these “trip free psychedelics” that are being studied and made work, i feel like losing the trip is losing a major component in the benefits of psychedelics. i’m sure they’ll have some degree of benefit, and i understand not everyone’s noggin works the same way as mine. but i have to feel like it’s going to inevitably nerf the positive effects and prevent them from showing the same results that classical psychedelics do in regards to studies for psychiatric treatment. maybe they’ll be particularly good for people who can’t take psyches, or for people who are at higher safety risks. either way, i’m incredibly interested to see where it’ll lead, in the wise words of Nye, Bill (Guy, Science) “Science rules :cool:
 
  • Like
Reactions: iom
Wow! Thanks for sharing. I'm especially curious if it can be used like ibogaine for addiction therapy.

I also read another TR published here (you may need a paywall blocker)
I'm very curious too! There is some research showing TBG's efficacy in alcohol and opioid addiction treatment in mice. https://pmc.ncbi.nlm.nih.gov/articles/PMC10286262/

I didn't have any ongoing addiction at the time of the report.
 
They keep calling this non-hallucinogenic, based on rodent behavior I guess, but the reports sure make it sound like a psychedelic to me. Also, non-hallucinogenic psychedelic is an oxymoron, isn't it? Here's another good one from that article (my emphasis):


There is also this: https://psychedelicalpha.com/news/n...rts-searching-for-the-tabernanthalog-tasters/

It's really a bit ridiculous to see all this "science-washing" of psychedelics in the process of bringing them into the mainstream when the root cause of their taint is the social taboo against tripping. That is still being ignored. Logically companies have the (profit) incentive to maintain these bizarre distinctions, because as long as "hallucinogens" remain illegal, these patentable "non-halluciongenic psychedelics" won't face legal market competition.

That's not to say I disapprove of this research. Ibogaine is physically risky, and a safer alternative (hopefully without losing the trip ;)) would be a huge win. Moreover, unlocking a mechanism for reseting opioid and other drug tolerances would also be a big deal.
I found that "non-hallucinogenic psychedelic" is actually a good description for TBG's effects. It doesn't distort reality in the sense that visual and audio perception continues to be in line with the consensus reality, so its non-hallucinogenic in that sense. But it produces distinct psychedelic bodily sensation typical for tryptamines, for example a feeling of compressed digestive tract, tingling in the hart and on the skin, waves of physical pleasure. Also the mind feels like in a typical psychedelic experience too, although calmer.
 
They keep calling this non-hallucinogenic, based on rodent behavior I guess, but the reports sure make it sound like a psychedelic to me. Also, non-hallucinogenic psychedelic is an oxymoron, isn't it? Here's another good one from that article (my emphasis):


There is also this: https://psychedelicalpha.com/news/n...rts-searching-for-the-tabernanthalog-tasters/

It's really a bit ridiculous to see all this "science-washing" of psychedelics in the process of bringing them into the mainstream when the root cause of their taint is the social taboo against tripping. That is still being ignored. Logically companies have the (profit) incentive to maintain these bizarre distinctions, because as long as "hallucinogens" remain illegal, these patentable "non-halluciongenic psychedelics" won't face legal market competition.

That's not to say I disapprove of this research. Ibogaine is physically risky, and a safer alternative (hopefully without losing the trip ;)) would be a huge win. Moreover, unlocking a mechanism for reseting opioid and other drug tolerances would also be a big deal.
Bro I am 100% with you on this. Fucking pharmaceutical companies.

I'm also pretty arrogant to a lot of the emerging so called experts in psychedelics, that took mushrooms once 2 years ago.
It's like they are just discovering things that we've known about for ages.

Sry rant over.
 
Top